| A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota H Watson, S Mitra, FC Croden, M Taylor, HM Wood, SL Perry, JA Spencer, ... Gut 67 (11), 1974-1983, 2018 | 430 | 2018 |
| Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer AJ Cockbain, GJ Toogood, MA Hull Gut 61 (1), 135-149, 2012 | 368 | 2012 |
| The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action ML Smith, G Hawcroft, MA Hull European journal of cancer 36 (5), 664-674, 2000 | 353 | 2000 |
| Audit of outcome of long-term enteral nutrition by percutaneous endoscopic gastrostomy MA Hull, J Rawlings, J Field, SP Allison, FE Murray, AS McIntyre, ... The Lancet 341 (8849), 869-872, 1993 | 314 | 1993 |
| Aspirin in the chemoprevention of colorectal neoplasia: an overview AT Chan, N Arber, J Burn, WK Chia, P Elwood, MA Hull, RF Logan, ... Cancer prevention research 5 (2), 164-178, 2012 | 310 | 2012 |
| Localization of cyclooxygenase-2 in human sporadic colorectal adenomas KS Chapple, EJ Cartwright, G Hawcroft, A Tisbury, C Bonifer, N Scott, ... The American journal of pathology 156 (2), 545-553, 2000 | 273 | 2000 |
| Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis NJ West, SK Clark, RKS Phillips, JM Hutchinson, RJ Leicester, A Belluzzi, ... Gut 59 (7), 918-925, 2010 | 266 | 2010 |
| Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? MA Hull, SCW Ko, G Hawcroft Molecular cancer therapeutics 3 (8), 1031-1039, 2004 | 209 | 2004 |
| Macrophage migration inhibitory factor promotes intestinal tumorigenesis JM Wilson, PL Coletta, RJ Cuthbert, N Scott, K MacLennan, G Hawcroft, ... Gastroenterology 129 (5), 1485-1503, 2005 | 186 | 2005 |
| Differential expression of cyclooxygenase 2 in human colorectal cancer J Dimberg, A Samuelsson, A Hugander, P Söderkvist Gut 45 (5), 730-732, 1999 | 175 | 1999 |
| Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice MA Hull, JK Booth, A Tisbury, N Scott, C Bonifer, AF Markham, PL Coletta British journal of cancer 79 (9), 1399-1405, 1999 | 161 | 1999 |
| Increased risk of colorectal cancer after obesity surgery M Derogar, MA Hull, P Kant, M Östlund, Y Lu, J Lagergren Annals of surgery 258 (6), 983-988, 2013 | 158 | 2013 |
| Obesity surgery and risk of cancer H Mackenzie, SR Markar, A Askari, O Faiz, M Hull, S Purkayastha, ... Journal of British Surgery 105 (12), 1650-1657, 2018 | 153 | 2018 |
| Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer P Kant, MA Hull Nature reviews Gastroenterology & hepatology 8 (4), 224-238, 2011 | 153 | 2011 |
| Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind … MA Hull, K Sprange, T Hepburn, W Tan, A Shafayat, CJ Rees, G Clifford, ... The Lancet 392 (10164), 2583-2594, 2018 | 132 | 2018 |
| MiR‐26b is down‐regulated in carcinoma‐associated fibroblasts from ER‐positive breast cancers leading to enhanced cell migration and invasion ET Verghese, R Drury, CA Green, DL Holliday, X Lu, C Nash, V Speirs, ... The Journal of pathology 231 (3), 388-399, 2013 | 129 | 2013 |
| Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the ApcMin/+ mouse DJ Scott, MA Hull, EJ Cartwright, WK Lam, A Tisbury, R Poulsom, ... Gastroenterology 121 (4), 889-899, 2001 | 122 | 2001 |
| Indomethacin induces differential expression of β-catenin, γ-catenin and T-cell factor target genes in human colorectal cancer cells G Hawcroft, M D'Amico, C Albanese, AF Markham, RG Pestell, MA Hull Carcinogenesis 23 (1), 107-114, 2002 | 117 | 2002 |
| Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid AJ Cockbain, M Volpato, AD Race, A Munarini, C Fazio, A Belluzzi, ... Gut 63 (11), 1760-1768, 2014 | 114 | 2014 |
| The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases SW Fenwick, GJ Toogood, JPA Lodge, MA Hull Gastroenterology 125 (3), 716-729, 2003 | 114 | 2003 |
